Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.83B
Close$
$-25.93
197.8% downside
Current Fair Value
197.8% downsideOvervalued by 197.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.83 Billion |
|---|---|
| Enterprise Value | $2.85 Billion |
| Dividend Yield | $0.90 (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.18 |
| Outstanding Shares | 104,326,669 |
Return
| Return on Equity | -8.00% |
|---|---|
| Return on Assets | -6.16% |
| Return on Invested Capital | -8.39% |
Valuation & Multiples
| P/E Ratio | -33.51 |
|---|---|
| PEG | -168.15 |
| Price to Sales | 26.51 |
| Price to Book Ratio | 2.65 |
| Enterprise Value to Revenue | 22.97 |
| Enterprise Value to EBIT | -26.07 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-1.09
Average shareholder expectationRevenue Estimate
$13.85 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$8.72 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 52.45% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 21.13%▼ 83.70% |
|---|---|
| Total Invested | $748.87M▼ 70.95% |
| Investors Holding | 105▼ 158.00% |
ESG Score
No data